How Mutant p53 Hijacks VWF Expression in Tumor Cells – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Noorossadat Seyyedi et al., adding:
”The role of mutant p53R175H in de novo activation of von Willebrand factor expression in tumor cells
Von Willebrand factor is normally made only by endothelial cells and megakaryocytes, yet some cancers switch it on.
Across 100 VWF-positive cancer lines, this study tied that aberrant expression to the mutant p53R175H, which engages the repressor NF-IB and activator GATA6 to drive VWF from the promoter.
The resulting VWF fueled cancer cell to platelet aggregates, and plakoglobin reversed the effect.”
Title: The role of mutant p53R175H in de novo activation of von Willebrand factor expression in tumor cells
Authors: Noorossadat Seyyedi, Chu Shiun Lo, Parnian Alavi, Manijeh Pasdar, Nadia Jahroudi
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026
-
Sep 4, 2026, 21:39Pierre Sabouret: A Good Surprise Our New Publication in Life Is Online